Eli Lilly (LLY) investors should expect fireworks this week as the pharma giant prepares to drop its bombshell Q4 2024 ...
and its preparing the ground with a restructuring of its business units. As of 5 September, Lilly's BioMedicines division will be split in two to form Lilly Neuroscience and Lilly Immunology ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results